News
Moderna, Inc. (NASDAQ:MRNA) shares soared to the top of the S&P 500 gainers in early afternoon trading on May 20, surging by ...
TrialWire is the AI and algorithm-powered patient-recruitment and enrollment platform, purpose-built on Salesforce Health Cloud to guarantee best-in-class data and IP security.
Betsy Groves, Ph.D., is a Solutions Architect at Cohere, where she serves as a trusted technical advisor helping enterprise ...
U.S. health officials are investigating a new outbreak of salmonella illnesses tied to a Florida grower whose tainted ...
The Food and Drug Administration has authorized more medical devices that incorporate artificial intelligence. Keep track of ...
Three-dimensional printing is transforming medical care, letting the health care field shift from mass-produced solutions to customized treatments tailored to each patient’s needs. For instance, ...
Tempus AI is expanding its partnership with Verastem Oncology to develop a companion diagnostic (CDx) for the latter’s KRAS-mutant recurrent LGSOC combination treatment.
On May 8, 2025, the Food and Drug Administration (FDA) announced the completion of its generative artificial intelligence (AI) pilot program ...
Tempus' FDA-approved xT CDx test is being used as an investigational assay in Verastem's global Phase 3 RAMP-301 clinical trial.
AstraZeneca PLC (NASDAQ:AZN), a pharmaceutical and biotech firm based in Cambridge, UK, reported positive results from its ...
With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting ...
Traditionally, HER2 status has been determined by immunohistochemistry (IHC) and in situ hybridization (ISH), distinguishing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results